From profit to impact: lives saved and the future of RSV vaccine development

Lancet Respir Med. 2023 Sep;11(9):763-765. doi: 10.1016/S2213-2600(23)00301-6.

¹ Department of Pediatric Infectious diseases and Immunology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht 3584 EA, Netherlands; Department of Pediatrics, St Antonius Hospital, Nieuwegein, Netherlands. Electronic address: n.i.mazur@umcutrecht.nl.
² Department of Pediatric Infectious diseases and Immunology, Wilhelmina Children's Hospital, University Medical Center Utrecht, Utrecht 3584 EA, Netherlands.

No abstract available